Skip to main content

Animations

MJFF Publications

1381 - 1390 of 8825 Results
Title
Year
  • Year
  • 2015
  • 2025
  • 2018
  • 2018
  • 2015
  • 2019
  • 2018
  • 2015
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddv453
    Citation Count: 78
  • Summary Details
    RESTRICTED
    Title: Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70053
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genetic variants related to urate and risk of Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.031
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathways
    Journal Name: Journal of Neural Engineering
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1088/1741-2552/aae12f
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Immunotherapy in Parkinson’s disease: Current status and future directions
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104587
    Citation Count: 66
  • Summary Details
    RESTRICTED
    Title: Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.009
    Citation Count: 116
  • Summary Details
    OPEN
    Title: Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-015-0449-7
    Citation Count: 120
  • Summary Details
    OPEN
    Title: A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.001
    Citation Count: 119
  • Summary Details
    OPEN
    Title: Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.038
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.